Estimation of disease progression parameters from case-control data: Application to mammographic patterns and breast cancer natural history

Journal of Epidemiology and Biostatistics

Volumn 6, Issue 2, 2001, Pages 235-242

  Couto, E ^a   Harrison, D A H ^a   Duffy, S W ^a   Myles, J ^a   Sala, E ^a   Warren, R M L ^a   Day, N E ^a   Luben, R ^a   Chen, H H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; Mammographic parenchymal pattern; Markov model; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PARENCHYMA; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MARKOV CHAINS; PROBABILITY; SENSITIVITY AND SPECIFICITY;

EID: 0035210616     PISSN: 13595229     EISSN: None     Source Type: Journal    
DOI: 10.1080/135952201753173015     Document Type: Article

References (12)

1. Case-control studies for estimation of the natural history of preclinical disease from screening data
2. Breast patterns as an index of risk for developing breast cancer
3. The Tabar classification of mammographic parenchymal patterns
4. Mammographic signs as risk factors for breast cancer
5. Size, node status and grade of breast tumours: Association with mammographic parenchymal patterns
6. Mammographic parenchymal patterns and mode of detection: Implications for the breast screening programme
7. Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49
8. Subroutines for unconstrained minimization using a model trust-region approach
9. Tumour development, histology and grade of breast cancer: Prognosis and progression
10. Modelling the analysis of breast cancer screening programmes: Sensitivity, lead time and predictive value in the Florence district programme (1975-1986)
11. Markov chain models for progression of breast cancer Part I: Tumour attributes and the preclinical screen-detectable phase